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ABSTRACT 
BACKGROUND 
Adherence is the ability to take the prescribed treatment within the period of persistence with the 
treatment. In the context of medical treatment, one may not be able to predict treatment non 
adherence in chronic conditions like hypertension. The researcher realized that a vast number of 
hypertensive patient in Kanye, Botswana live with poorly controlled blood pressure; Adherence 
was identified as one of the factors that impact on treatment outcome. Aim of the study was to 
determine the factors that affect adherence to treatment in adults with hypertension. 
METHOD 
The study was a cross-sectional study; of 200 adult persons with hypertension who attended the 
clinics in Kanye. A structured questionnaire was used to collect data. 
RESULTS 
The result showed that there was a significant association between the outcome (adherence level) 
and the counseling on the risks of uncontrolled hypertension (P-value= <0.0001. Chi2=116.667), 
patients’ experience with pill burden (P-value= <0.0001, Chi2= 40.9091), patients understanding 
of treatment regimen (P-value=<0.0001, Chi2 = 150.0000), patients perception of treatment 
benefits (P-value = <0.0001, Chi2 = 150.0000), emotional wellbeing (P-value = <0.0001, Chi2 = 
141.1765), patients’ perception of drug adverse effects (P-value = <0.0001, Chi2 = 108.1434) 
and cost of medication (P-value = 0.0108, Chi2 = 4.1455). 
CONCLUSION 
The study showed that patients who were counseled on the risk of hypertension and understood 
the treatment regimen adhered better to treatment. The perception of treatment benefits, reduced 
number of pills taken in a day, good family support and availability of medications are the other 
factors that affected adherence. 
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BACKGROUND AND INTRODUCTION 
Hypertension is the sustained elevation of blood pressure above that defined for age, sex and 
race. The goal blood pressure is 140/90mmHg or 130/80mmHg for adults with diabetes or renal 
disease.
1
  
Hypertension is strongly associated with the development of cardiovascular disease in sub 
Saharan African populations.
2
 Cardiovascular disease is the second most common cause of death 
in the region (after HIV/AIDS and communicable diseases), but is the most common cause of 
death of those above the age of 30 years.
3
 The treatment of hypertension reduces the risk of 
developing complications such as stroke, cardiac failure and peripheral vascular disease. Some 
regional data suggest that 30-50% of stroke mortality occurs in the context of uncontrolled 
hypertension.
4
 
Adherence is the ability to take the prescribed treatment within the period of persistence with the 
treatment. It is an important factor in determining treatment outcome especially in chronic 
medical condition where medication adherence is a challenge to patients.
5
 Many patients are 
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likely to adhere to treatment if they understand that the benefits of treatment outweigh the 
deleterious effects of treatment.
6
 
The data from the district hospital in Kanye showed that on the average, 10 patients were 
admitted and managed for hypertensive complications in a month. Between 01/01/10 – 31/12/10, 
92 patients were admitted and managed for stroke and heart failure arising from hypertension, 
over this period, 10 deaths was recorded. 
Medical Officers in Kanye see an average of 60-80 hypertensive patients weekly. Quite a large 
percentage had persistent uncontrolled blood pressure. This evoked the question “why do some 
of these patients persist with uncontrolled blood pressure despite adequate treatment” By 
adequate treatment; a patient must have been on maximum doses of two blood pressure lowering 
drugs for 6 months and above. With a step further, the researcher then asked a question “What 
are the factors that affect adherence to treatment in adult patients with hypertension in Kanye?” 
The WHO report says there is a 28% prevalence of hypertension among the 25 – 64 year old.7 
Kanye has a District Health Management Team (D-H-M-T) that oversees the operations of the 
seven primary health care clinics and the district hospital.  The findings of this research will 
assist the D-H-M-T in defining the administrative and treatment protocols that will help in 
patients’ care.  
LITERATURE REVIEW 
Relevant articles were retrieved through systematic searches of Medline and Cochrane data bases 
using keywords ‘hypertension’ and ‘adherence’ to enable an appropriate assessment of the major 
issues in adherence as it relates to barriers to adherence and ways of improving them. The search 
identified all articles and abstracts published in medical journals from 1995 to date. The 
literature review evaluated the factors that affect adherence to medical treatment in adult patients 
with hypertension.
8
 
The disease burden 
In the United States of America, 24% of American adults had hypertension.
9
 Overall, two thirds 
of the population with hypertension was aware of their diagnosis (69%) and a majority (53%) 
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was taking prescribed medications.
4
 Furthermore, the prevalence of hypertension is higher in the 
older individuals, non-Hispanic blacks and women.  Patients’ failure to adhere to medication 
regimen may cost as much as $300 billion to the healthcare systems in the United States.
10
 
In a study of  hypertension  prevalence and blood pressure levels in six European countries, 
Canada and the Unites States, the study indicates that the age- and sex- adjusted prevalence of 
hypertension was 28% in the North American countries and 44% in the European countries at the 
140/90mm Hg threshold.
11
 
Hypertension in South Africa is referred to as a-‘silent epidemic’.12 A cross sectional 
cardiovascular disease (CVD) risk factor survey was conducted by Connor et al and found 
hypertension to be the commonest of the CVD risk factors amongst the study population. The 
prevalence rate was 55%, with 59% in black African people, 55% in both Indian and colored 
people and 50% in white people.
13
 
In Botswana, the prevalence rate of hypertension among the adult population is 28%
7 
 
 
Adherence to management 
Adherence is said to be the extent to which a person sticks to the prescribed management 
protocol. Persistence with a particular drug varies especially with the presence of an adverse 
effect.
14
 Generally, adherence is poor in chronic conditions especially if the treatment benefits 
are not readily appreciated.
15
 Randomized trials have demonstrated that reduction of high blood 
pressure by 5mmHg with medication can substantially reduce the risk of stroke by 34% and of 
ischemic heart disease by 21 percent.
16
 Adherence in patients with treated hypertension is 
estimated between 50% and 70%, and the importance of improving adherence to long-term 
therapies has recently been addressed by the World Health Organization in a 2003 report.
17
 
  
Measurement of adherence 
There are a number of ways of measuring patients’ adherence to taking medications. The direct 
measurement involves the detection of a metabolite in the body fluid. Though very accurate, it is 
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costly, difficult to perform and therefore not feasible in this context.
18
 The indirect methods of 
measuring adherence are most commonly used. These involve interviewing, tablet counts, 
diaries, and prescription refilling dates.
11
 These measures though commonly used are less 
reliable. 
 
Factors affecting adherence  
Adherence to treatment regimen varies as a result of a complex interaction between the patient, 
provider and the health system.
19
 Patients’ non adherence with prescribed treatment is a central 
reason for the failure to control hypertension in those receiving therapy.
20
 Investigations have 
identified physician related factors, perception of treatment benefits, perceived adverse effects, 
cost of medication, emotional well-being, pill burden, duration of treatment, age of the patient, 
accessibility to health care and understanding of treatment regimens as factors that affect 
adherence to treatment.
21-22
  
Many researches have supported the claim that improvement of the doctor-patient relationship 
improves adherence.
5
 The frequency of interaction between the patient and the doctor, the 
duration and the quality correlates with adherence.
23
 
Patients’ perception of the threat posed by hypertension, the effectiveness of treatments and the 
importance of complying with therapy are variables that are also receiving attention.
24
 
Drugs with fewer side effects improve adherence.
25
 In a study by Youssef et al, 10% of the study 
population did not adhere with treatment simply because they wanted to avoid drug side effect.
26
 
Depression is a risk factor for poor adherence. It has been associated with greater sensitivity to 
unpleasant side effects of drugs.
27
 In a study by Carney et al, adherence with aspirin among 
elderly patients with coronary artery disease was studied; it was found that depressed patients 
adhered to their medication in a significantly lower proportion of days (45%) than those without 
depression (69%)
 28
 
Adherence to concomitant lipid-lowering and hypertensive medications falls by an average of 
9% with each additional background prescription drug a patient is on.
29
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Adherence to medication tends to be better in short treatment courses and tends to reduce in 
patients who are to medication for a long period.  
An assessment of the factors that affect adherence in an audit on the treatment of hypertension in 
general practice revealed that patients below the age of 55 years and those above 65 years 
adhered poorly to treatment medications compared to those between ages 55-65 years.
30
 
The complexity of the prescription affect treatment adherence.  In a study published in 1997, of 
527 patients with arthritis who were prescribed non-steroidal anti-inflammatory drugs, an inverse 
linear relationship was found between the numbers of doses a day and adherence. Adherence was 
78% for once a day dosing, 72% for twice a day dosing, 64% for thrice and 60% for four times a 
day dosing.
31
 
Some other factors mentioned that affect adherence include forgetfulness, alcohol use, lack of 
knowledge about blood pressure and psychiatric disorders; the more symptoms reported, the 
lower the adherence.
32
 
 
How to improve adherence to blood pressure lowering medication  
At most 50% of people with chronic disease comply with their doctor’s recommendations, 
irrespective of disease, treatment or age.
33
The current methods of improving medication 
adherence are complex, labor-intensive, and not predictably effective.
34
 Simplified treatment 
regimen, accessibility of the heath facility, discussing adverse effects and encouragement of 
family support could positively affect adherence.
11
 
 
Simplified treatment regime 
Simpler medication regimens improve adherence in patients with hypertension. Research studies 
in this aspect showed that once daily medication gave a better adherence rate than multiple 
dosing and should be tried as a first line method of improving adherence.
27-28
In another study 
conducted in New York; fixed dose combination resulted in a 26% decrease in the risk of non-
adherence compared with the free-drug component regimen.
29
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 RESEARCH QUESTION 
What are the factors that affect adherence to treatment among adult patients with hypertension in 
Kanye, Southern District council, Botswana? 
 AIM 
To determine the factors that affect adherence to treatment in known adult hypertensive patients 
in Kanye sub district. 
OBJECTIVES 
1. The study tested the effect of the following factors on adherence to treatment. 
 Patient’s knowledge of the disease condition 
 Accessibility to health care facility 
 Duration of treatment 
 Pill burden 
 Availability of prescribed drugs 
 Perceived adverse effect of medication 
 
METHOD 
Study Design: The design was a cross-sectional analytical study. 
The setting of the study was the outpatient departments of the clinics in Kanye. 
Study Population: The study population was the adult hypertensive patients that attended the 
seven clinics (Kanye Main Clinic, Mmamokhasi, Dilolwe, Sebego, Mafhikana, Dada and 
Kgwatlheng clinics) in Kanye. 
Sample size: 
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The study sample size was 200 hypertensive patients. It was derived from an automated 
calculator using a 28% prevalence rate among a population of 40,628 persons in consultation 
with the Center for Statistical Consultation, University of Stellenbosch. 
Adherence rates 
The patient’s self- reporting of adherence was used in this study to assess adherence levels. It 
resulted to 2 possible outcome variables 
i. Adherent 
ii. Non adherent 
Adherent meant that patient took prescribed drugs fully or took more than 80% of the drugs 
whereas non adherent is taking less than 80% of the prescribed drugs. Patients who were 
adherent were those who missed taking medications for six days or less. 
Inclusion Criteria 
The study included only adults with hypertension from 18 years and above who lived in Kanye. 
Patients living with other chronic conditions who have hypertension were included. The patient 
must have been on hypertensive treatment for a period not less than 6 months. 
Method of Data Collection 
A systematic sampling method was used to select the study sample. Every second patient who 
came for review was sampled and the selected patients were coded.   The questionnaire 
(Appendix 1) was self- administered but the researcher and two other trained health workers 
assisted the subjects who could not read or write. Data was collected over a period of thirty days. 
The setting for data collection was a designated room with minimal interruption during 
interviewing.  
Validity of the data collecting tool 
The data collecting tool was validated after a thorough Medline search and review of Cochrane 
data bases 
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Pilot study 
A pilot study was to test run the questionnaire for problems. The pilot gave a general overview of 
how the study will go and allowed for the fine tuning on the practical procedures.  
The pilot study was carried out at Kanye Main Clinic located at the central part of the village. 
The pilot was carried out on patients with similar characteristics as those that participated in the 
study but were not included in the study themselves  A small population of about 10 patients was 
selected. Each of the patients signed consent after adequate information about the study was 
given. 
Data Analysis 
The statistical package STATA version 10 was used for data entry and analysis. The assistance 
of the university statistician was employed for this task. Mean, standard deviation, odds ratio and 
corresponding 95% confidence interval was computed.  Pearson’s chi-square test of association 
was used to test the strength of association between independent and dependent variables. 
Logistic regression analysis was used to model patients’ adherence to medication as a function of 
demographic characteristics, medication cost, the perception of adverse effect, perception of 
treatment benefits, emotional wellbeing, physicians’ factor, and availability of prescribed 
medication. 
 Ethical Consideration 
The research proposal was approved by the University of Stellenbosch Human Research Ethics 
Committee (Reference Number=N11/04/105) Permission was also obtained from the Botswana 
Ethics Committee, Health Research Unit of the Ministry of Health. In the course of the study, the 
researcher referred all subjects found to have uncontrolled blood pressure to a physician for 
management.  
 
RESULTS  
The study was carried out over a thirty day period on two hundred participants. 
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Table1. Tabulation of demographic features of study population (N=200) 
The table below shows the age distribution of the study population, age and marital status 
Variables Frequency Percent 
 
Age category in years 
30 – 39 14 7.00 
40 – 49 39 19.50 
50 – 59 61 30.50 
60 – 69 54 27.00 
70 - 79 26 13.00 
> 80 6 3.00 
 
Gender 
Male 63 31.50 
Female 137 68.50 
 
Marital status 
Married 82 41.00 
Single 44 22.00 
Divorced 12 6.00 
Widowed 44 22.00 
Co-habiting 8 4.00 
Engaged 10 5.00 
 
In the community where the research was carried out, more females have high blood pressure 
and a majority of them fall within the middle age. The demographic date above appears to be a 
true representation of the hypertensive population attending these clinics. 
 
 
Table 2: Tabulation of study population’s accessibility to the health facility (N=200) 
The result shows mode of transportation used by the study population to get to the health facility. 
It also shows if the cost of transportation is cheap, affordable or expensive. 
 
Variable Frequency Percent 
 
Mode of transport 
Walking 156 78.00 
Public Transport 23 11.50 
Private car 21 10.50 
 
Cost of transport 
Cheap 175 87.50 
Affordable 10 5.00 
Expensive 15 7.50 
 
Distance from Facility 
< 5 km 179 89.50 
5 – 8 km 18 9.00 
>8 km 3 1.50 
 
Table 2 shows that 89.5% of the population studied lived within 5km of the nearest clinic and 
considered that accessing the clinic was cheap. 
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Table 3: Tabulation of knowledge on hypertension of the study population (N=200) 
The result shows patients understanding of the meaning of hypertension and the reason why they 
take drugs. 
 
 
Variable Frequency Percent 
 
Meaning of hypertension 
Increased blood volume 39 19.50 
Increased blood pressure 61 30.50 
Abnormal blood 23 11.50 
I do not know 77 38.50 
 
Counseled on risk 
Yes 140 70.00 
No 60 30.00 
 
Why do you take drugs 
To cure 20 10.00 
To control 65 32.50 
To stay alive 27 13.50 
Avoid complication 38 19.00 
Do not know 50 25.00 
 
The findings on the study population’s knowledge of hypertension varied. 19.5% understood 
hypertension to be increase in blood volume, 30.5% knew hypertension was increase in blood 
pressure and 11.5% understood it to be abnormal blood in the body. On the other hand, 38.5% 
had no meaning for hypertension. Overall, 31% of the population had a different understanding 
of blood pressure other than ‘increased pressure’. More than half of the population (70%) had 
been counseled on the risk of uncontrolled hypertension. 
 
  
Stellenbosch University  https://scholar.sun.ac.za
15 
 
Table 4: Tabulation of the Treatment History of the Study Population (N=200) 
The table shows the study population’s knowledge of their drugs, the number of classes of drugs 
taken and the dosing frequency 
Variable Frequency Percent 
 
Duration on Treatment 
6 – 12 months 18 9.00 
> 12 months 163 81.50 
Unknown 19 9.50 
 
Do You Know Your Drugs (names) 
Yes 150 75.00 
No 50 25.00 
 
Classes of Drugs Taken in a Day 
1 class 75 37.50 
2 classes 114 57.00 
3 classes 11 5.50 
 
Dosing Frequency per day 
Once Daily 91 45.50 
Twice Daily 88 44.00 
Thrice Daily 21 10.50 
 
The treatment history of the study population shows. 75% of the population know the names of 
their medications. 
37.5% of the study population used a class of blood pressure lowering drug while more than half 
of the study population (57%) used two classes and 5.5% used three classes of blood pressure 
lowering drugs. Overall, it showed that 89.5% had a dosing frequency of two times or less a day 
which is considered to be a simplified dosing frequency.  
Table 5: Tabulation of Comprehension of Adherence (N=200) 
The result below assessed if the patients were counseled on the dangers of poor adherence. For 
the study, adherence is poor if a patient missed taking medication for more than six days over a 
thirty day period that adherence was measured. 
Variable Frequency Percent 
 
Counseled on Dangers of Poor Adherence 
Yes 150 75.00 
No 50 25.00 
 
How Often do You see Your Doctor 
Every check-up 35 17.50 
Once a month 135 67.50 
Once in 3 months 22 11.00 
Once in 6 months 4 2.00 
Once a Year 1 0.50 
Occasionally 3 1.50 
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Table 6: Tabulation of Comprehension of Adherence (N=200) 
The table shows the population’s understanding of the dangers of poor treatment of hypertension 
and how adherence can be improved. 
Variable Frequency Percent 
 
Dangers of poor treatment 
No danger 9 4.50 
Poor control of BP 72 36.00 
Poor quality of life 49 24.50 
Complications  52 26.00 
Do not know 18 9.00 
 
How can we improve adherence? 
Counseling 69 34.50 
Home visit 42 21.00 
Regular check - ups 54 27.00 
Decrease number of pills 35 17.50 
 
The result of comprehension of the importance of medication adherence showed that 4.5% 
reported that there is no danger associated with poor adherence and 9% said they did not know. It 
also indicated that 86.5% knew that poorly treated hypertension posed a threat to their lives 
34.5% agreed that counseling them regularly may improve their adherence, 21% think that home 
visits may improve adherence, 27% think they may improve when they get regular check-ups 
and17.5% reported that decreased number of pills may make them adhere better.   
 
 
Table 7: Tabulation of Self Adherence Report of the Study Population (N=200) 
The table shows the result of patients self-report of adherence. It shows if a patient missed taking 
medication in the previous thirty days that adherence was measured. 
Variable Frequency Percent 
 
Do you miss Appointments 
Yes 20 10.00 
No 180 90.00 
 
Days of missed medication 
None 50 25.00 
 6 days or less 90 45.00 
> 6 days 60 30.00 
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The majority of the study population (90%) said they did not miss their appointments with the 
health worker. 70% reported good adherence level in the preceding 30days and 30% said they 
missed taking medication for more than 6 days in the last 30 days.  
Table 8: Tabulation of Medication Availability in the clinics (N=200) 
The result shows whether hypertensive medications are always available in the health facilities 
Variable Frequency Percent 
 
Medications availability 
Yes 23 11.50 
No 177 88.50 
 
If No, why 
Not applicable 23 11.50 
Medication not available 177 88.50 
 
88.5% reported that their medications were not always available and it made them miss taking 
medication properly. 
Table 9: Tabulation of Emotional wellbeing of the Study Population (N=200) 
Family support was defined as the ability of family members to support their relative who has 
hypertension and who remind them to take medications and go for check-ups. 
Variable Frequency Percent 
 
Family support 
Yes 170 85.00 
No 30 15.00 
 
Family support improves adherence 
Yes 197 98.50 
No 3 1.50 
 
85% admitted that they have family support in the management of their medical condition. 
However, 98.5% said that family support may improve their management. 
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Table 10: Tabulation of drug side effects in study population (N=200) 
The result shows if drug side effects are experienced by the patients, if they are checked for side 
effects and the actions taken when side effect is experienced. 
Variable Frequency Percent 
 
Side effects experienced 
Yes 59 29.50 
No 141 70.50 
 
Side effects checked for by the doctor 
Yes 115 57.50 
No 85 42.50 
 
Actions taken by the patient 
No remedy 106 53.00 
Stop Medication 34 17.00 
Report to facility 60 30.00 
 
29.5% of the study population had experienced an adverse drug event. Patients thought that the 
clinician checked patients for drug side effect in 57.5%. Fifty three percent of the study 
population did not take any action when they experienced drug adverse reaction, 17% stopped 
the medication when adverse event was experienced and 30% reported immediately to the health 
facility. 
Table 11: Tabulation of disease co-morbidities acknowledged by the patients in the study 
population (N=200) 
The result shows the number of the population who have other chronic diseases other than 
hypertension, those who were diagnosed with depression. 
Variable frequency Percent 
 
Chronic disease Present other than hypertension 
Yes 99 49.50 
No 101 50.50 
 
Depression diagnosed 
Yes 25 12.50 
No 175 87.50 
 
Drug for other chronic diseases like arthritis, diabetes, HIV/AIDS 
Yes 99 49.50 
No 101 50.50 
 
49.5% of the study population had an additional chronic medical condition like asthma, 
HIV/AIDS, Diabetes mellitus and osteoarthritis, with 55% on medications for chronic illnesses 
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in addition to blood pressure lowering drugs. A small percentage of the study population (12.5%) 
had been diagnosed with depression. 
Table 12: Tabulation of adherence level of the study population (N=200) 
Variable Frequency Percent 
Adherent 140 70.00 
Non adherent 60 30.00 
 
The 70% adherence level observed in this study is below the 80% adherence level set for this 
study. 
 
The result shows significant association (tested for by Pearson’s chi-square test of association) 
for seven of the independent variables and adherence. 
Table 13: Relationship of measured variables with adherence 
Tabulation of variables 
 
Chi^
2
 Values P - Values 
 
Adherence by counseling on risk of uncontrolled BP (Physician related factor) 
 
116.6667 
 
<0.0001 
 
Adherence by increased number of pills taken by patients (Chronic treatment) 
 
40.9091 
 
<0.0001 
 
Adherence by Understanding of treatment regimen (Know names/identify drugs) 
 
150.0000 
 
<0.0001 
 
Adherence by Perception of treatment benefits (why drugs) 
 
150.0000 
 
<0.0001 
 
Adherence by Family support 
 
141.1765 
 
<0.0001 
 
Adherence by Patient  Perception of adverse effects 
 
103.1434 
 
<0.0001 
 
Adherence by medication not available 
 
6.4972 
 
0.0108 
 
There was a significant association between adherence level and the counseling on the risks of 
uncontrolled hypertension, patients’ experience with pill burden, patients understanding of 
treatment regimen, patients perception of treatment benefits, emotional wellbeing, patients’ 
perception of drug adverse effects and cost of medication. 
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There were no associated variables that remained associated at the end of the logistic regression 
analysis. 
 
 
DISCUSSION 
Long-term adherence with antihypertensive medication regimens has been poor. In one study, 
only 49% of patients took more than 80% of their prescribed dosages during the first year of 
treatment.
35
Other studies indicate that 16% to 50% of hypertensive patients quit taking their 
medications within the first year of treatment.
36
 
Improved adherence to treatment in hypertension has been associated with reduced morbidity 
and mortality.
37
 Studies in the past showed that adherence to treatment in hypertension can vary 
from a low 50% to a high 80%. This has been attributed to varying methodological approach 
used in setting the adherence levels.
26
 
The 70% adherence level observed in this study falls within the adherence levels observed in 
other studies. Adherence level was based on patient self-reporting which can be exaggerated. It is 
generally accepted that patients’ reporting of non-adherence is reliable but the denial of non-
adherence is not entirely correct; however, patient self-reporting of adherence is recommended in 
clinical practice because it is simple and has been proven to be fairly accurate.
26
 There was a 
high adherence level despite the fact that 25% of the studied population did not know the reason 
why they were on treatment. This could be due to the strong family support the study population 
had from family members. 
The high adherence level observed in this study could be because treatment is provided to the 
citizens of Botswana at no cost.  Another reason for the high adherence level observed in this 
study could be attributed to the fact that adherence was checked for the last thirty days of taking 
treatment. 
This study demonstrated that there is an association between physician’s related factors and 
patients’ adherence outcome levels. The study showed that 25% of the population did not know 
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the reason why they were on hypertension treatment. It gave a P-value <0.0001 which means that 
there is a significant statistical association between understanding the reason for treatment and 
medication adherence. This reason could be that some of the clinics where the study was carried 
out did not get doctor’s visit on a daily basis, which could result in some patients not being 
counseled before they were started on treatment.  Patients who were educated on hypertension by 
their health care providers are likely to adhere to treatment more than those who were not 
educated by their physicians. This has a similar trend in a study done by Yiannakopoulou et al; it 
demonstrated that adherence is associated with more effective BP control. Physicians can 
enhance patient adherence and hypertension control by devoting more time to counseling, 
avoiding unnecessary changes in drug regimens and restricting the tablets numbers.
38
 
Adequate counseling on the risks of uncontrolled hypertension can also affect patient’s 
adherence level. The study revealed that 30% of the population studied admitted that they were 
not counseled by their health care provider and this group, n=60, reported being non adherent. 
This finding is similar to what was demonstrated in 2005 by Yiannakopoulou et al.
38
  
This study indicated a significant association between patient’s perception of treatment benefit 
and adherence level, patients who believe that they are vulnerable or susceptible to the 
consequences of the disease tend to adhere to prescribed treatment more than those who do not 
understand the reason for treatment.
27
 On the other hand, 25% did not know the benefits of 
treating hypertension. Patients who did not know the health benefits of treating hypertension 
could be that they were not adequately educated on hypertension by the heath care provider.                                                              
Drug adverse effect is a primary reason why patients on antihypertensive therapy adhere poorly 
to treatment.
25
 In one study done in 1999, it showed that 34% of the patients reported 
unacceptable adverse drug events which made them discontinue their therapy.
39
 The finding in 
this study showed that 29.5% experienced adverse drug events and 17% out of this population 
stopped taking their medication. The analysis showed a statistically significant finding when 
patients’ experience of drug adverse event was analyzed against adherence. It therefore means 
that drug adverse event experienced by patient impacts on his medication adherence.  
In our study, it was demonstrated that the higher the number of pills a patient is taking, the less 
the adherence and 55% of the population studied were also on medications for another chronic 
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disease. The analysis shows that the higher the number of medications a patient is taking for 
different diseases, the lower the adherence. Pill burden is a challenge among some of the patients 
in the study population. The most important reason is that combination tablets and sustained 
release tablets are rarely available in the public sector in Botswana; therefore patients are 
prescribed multiple medications with increased dosing frequency when a chronic medical 
condition is present. A similar finding by Iancin in 2006 showed that adherence to medications 
fall by an average of 9% with each additional prescription drug a patient is on.
29
 
Among the population studied, 15% reported that they had no family support. This could result 
from patients having lost close family members to illnesses like HIV/AIDS. There was a 
significant association between adherence and whether the patient had a stable family support. In 
a study that looked at psychosocial risk factors and adherence, a similar trend was reported.
40
 
The ability of the patient to know the medications he is on and how to take them improves 
adherence. 25% of the patients in this study did not know their medication(s) either by name or 
ability to identify them. This was significant in the chi square test of association. This means that 
patients who do not know their drugs and how to use them had a lower adherence to treatment 
when compared to their counterparts who knew their drugs and how to use them. In a study by 
Atreja et al, they showed that simplifying the treatment regimen to the patient’s understanding 
enhances adherence.
41
 
Medications are provided to the citizens of Botswana for free and cost of medication is not 
expected to be a barrier to adherence; nonetheless, 88.5% reported that drugs were not always 
available at their health facilities. This could result in patients being forced to buy medications 
from the private pharmacy shops. The cost of medication is shown to be a barrier to adherence.  
The Chi square test of association showed that medication non-availability may have impacted 
on medication adherence.   
The study of the patient’s age showed that 16% of the study population was above seventy years. 
In one study, was reported that patients above sixty-five years of age adhere poorly to 
treatment.
34
 
In this study, accessibility to health care facility did not impact on medication adherence; the 
reason may be because 98.5% of the population lived within eight kilometers from the health 
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facility, which enhanced accessibility. The patients studied reported that accessing the facility is 
cheap because majority of them walk to their health facility. This is similar to the report by 
WHO (2003) which states that long distance from the treatment center is one of the 
socioeconomic factors that affect adherence to long term therapies.
6
 
 
Limitations of the study 
 Adherence level was measured over only the preceding 30 days and could have resulted in the 
high adherence level observed. This was a cross sectional study. A systematic sampling method 
was used to select the study population and data was collected by interviewing patients, the data 
collected were prone to some measurement bias from the study subjects and the interviewer, 
examples were errors in the estimation of the number of the study population, recall bias, errors 
in estimating the level of adherence to treatment from the patient etc. Cross sectional studies 
demonstrate associations and are reported as observations; therefore it has a reduced weight of 
proof as compared to a research with cause and effect relationship. 
 
 
RECOMMENDATIONS 
Based on the findings in this study, the following recommendations were proposed. 
 Physicians are encouraged to educate patients adequately through patient centered 
approach and help patients understand the meaning of their medical condition; counsel 
them on the associated risks and dangers of poor adherence. The physician should 
endeavor to confirm their patients’ understanding by giving them the opportunity to 
clarify their understanding.  
 Health care workers are encouraged to check patients for drug adverse effect at all times 
to enable prompt identification of side effects and its management. 
 The health care workers are advised to adhere to rational prescribing by using available 
guidelines on hypertension treatment. 
 The Kanye District Health Management Team is advised to see ways of improving the 
medication availability in the district.  
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CONCLUSION: 
The findings in this research have shown that physician’s related factors have a great influence 
on the patients’ adherence level to treatment. Patients who were adequately counseled by their 
physician were more likely to adhere to treatment compared to those who were not counseled. It 
has also been established that patients’ understanding of the treatment regimen and patients’ 
perception of the treatment benefits are some other factors that enhance adherence in a patient 
with a chronic medical condition like hypertension. Those who did not understand the regimen 
are more likely to adhere poorly compared to those who understood the regimen. The drug 
adverse effect is another important factor seen to affect adherence as shown in this study. 
Patients who experienced side effects are more likely to be non-adherent compared to their 
counterparts who did not experience any drug side effects. The number of pills a patient takes in 
a day also impacts on adherence. Patients who take many tablets and for increased number of 
times in a day are more likely to adhere poorly compared to those who take one tablet once a 
day. Finally, the patients’ emotional state is a very important factor that improves adherence. 
Patients who had family support adhered better than those who did not have family support. 
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APPENDIX 1 
Instruction: This questionnaire is for the purpose of research. Your personal details are not require and 
no information given will be disclosed in any form 
Tick (   X    ) where appropriate 
 
Date...........................     Instrument Number........................... 
 
SECTION A    General Information 
 
1. Age in years......................... 
 
2. Gender  Male    Female 
 
3. Marital status  Married  Single   Divorced/Separated    
 
   Widowed    Co-habiting Engaged 
 
 
4. Educational Level Completed   None  Primary   Secondary 
     Tertiary (Specify)  Vocational 
 
5. Employment status  Employed  Unemployed  Student 
   Volunteer  Self-employed(specify)   
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6. How much do you earn per month in Pula?  No income  0-999  1000-
1999   2000-2999  3000 and above   
 
7. How do you get to the health facility? Walking  Public transport 
 private car    others (Specify)..................................... 
 
8. How do you grade the cost of transport?  Cheap   Affordable  
     Expensive          
  
9. Do you incur any other cost other than transport in getting to the health facility?   
 Yes  No  
 
10. How far is the health facility away from your home? Less than 5 km   
 5 – 8Km   More than 8Km        
 
 
SECTION B    CLINICAL INFORMATION 
 
 
11. What does hypertension mean to you?   Increased blood volume  
 Increased blood pressure        abnormal blood in the body  others 
(Specify)...............  
12. Have you been counseled on the risks of uncontrolled hypertension? Yes  No 
 
13. Is hypertension curable?  Yes  No 
 
14. Why do you take blood pressure lowering drugs?  To cure  To Control 
 To stay Alive  To avoid complications like stroke, heart failure   
 No benefit  others (Specify)..................         
15. How long have you been on blood pressure lowering drugs? Less than 6 months 
 6 – 12 months  more than 12 months  Unknown  
 
16. Do you know your hypertension drugs and how to use them? Yes  No 
 
17. Current hypertension treatment 
  
Antihypertensive  
Diuretic (Amiloretic/B.thiazide/hydrochlorothiazide  
ACEI (Enalapril/ Captopril)  
Calcium Blockers (Nifedipine/ Amlodipine)  
B-blockers (Atenolol/ Propranolol/ Bisoprolol)  
a-methyldopa (methyldopa)  
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Others (specify)  
 
18. How many hypertension tablets do you take in a day? 1 tablet         2 tablets 
 3 tablets   4 tablets      5 tablets 
 
19. How many times a day do you take hypertension tablet?  Once daily         
Twice daily   Thrice daily   > 3 times   
              
20. Has the regimen ever been changed?  Yes  No 
 
21. If yes, how many times?  Once  Twice  Three times or more  
  Cannot remember   
    
22. Reasons for changing regime?  Adverse/side effect  Unavailability   
 Too sick to go for refill  Poor blood pressure control 
 Unknown 
 
SECTION C    ADHERENCE COUNSELLING 
 
23. Have you been counseled on the dangers of not taking hypertension treatment properly? 
 Yes  No 
 
24. If yes, who counseled you on adherence? Doctor   Nurse  
 Pharmacist/Pharmacy technician  others (Specify)............................ 
 
25. How many times did you receive adherence counseling after you started treatment? Once 
 Twice  Three times  Four times  More than five times  
 
26. How often do you see your doctor about your hypertension treatment?   
 At every check-up   Once a month  Once in three months  Once in 
6 months   Once a Year  Occasionally   Others 
(Specify)................................... 
 
27. What are the dangers of not taking your drugs regularly?  No Danger  
 Poor control of blood pressure  Poor quality of life    Onset 
of hypertension related complications  others (Specify)............. 
 
 
28. How can we make you take your drugs regularly?        Counseling         Home visits  
Regular check-ups          Decreased number of drugs                  others (Specify)................ 
             
Stellenbosch University  https://scholar.sun.ac.za
31 
 
             
      
SECTION D    SELF ADHERENCE REPORT 
29. Do you miss appointments to the clinic?      Yes        No 
 
30. If yes, which ones among these make you miss appointments to the health facility? 
Felt better/stable  Alcohol use  Traditional medication  
Clinic was not accessible  I forgot    
Depressed/ lack of 
interest in treatment 
 Lack of transport to the 
clinic 
 Did not understand 
instructions 
 
Too many pills  Ran out of pills  Others specify  
Hospitalized  Due to side effects of 
drugs 
   
 
 
 
31. Are your medications always available at your health facility? Yes  No 
 
32. If, no, what is the reason(s)?  Medications not available  Facility is closed 
    others (specify)....................... 
 
33. How many days in the past 30 days have you missed taking blood pressure lowering drugs? 
None    < 6 days     > 6 days 
34. Do your family members give you the support you need in the course of management of your 
hypertension?  Yes  No 
 
35. Will family support make you adhere better to treatment? Yes  No 
 
SECTION E   SIDE EFFECTS/ADVERSE REACTION 
36. Have you experienced any of these side effects after taking you hypertension treatment? 
You can choose more than one option 
Side effects/adverse reaction Yes No 
Nausea/ feeling like vomiting (Methyldopa)   
Vomiting (Methyldopa)   
Headache (Nifedipine/Amlodipine)   
Dizziness (Thiazide/Hydrochlorothiazide)   
Diarrhea (Nifedipine/Amlodipine)   
Poor night sleep (Propranolol/Atenolol)   
Prolonged dry cough (Captopril/Enalapril)   
Dry mouth/ increased thirst   
Loss of libido/low sex drive 
(Propranolol/Atenolol) 
  
Depression /low mood (Methyldopa)   
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Leg swelling  (Nifedipine/Amlodipine) 
Rash (Methyldopa) 
Others (please specify) 
 
 
  
 
37. Are you checked for the above side effects by your heal care provider? Yes  No 
 
38. What remedies or action do you take when you experience side effects or adverse reaction? 
No remedy  Stop medication  Report to the health facility   others 
(specify).........................   
 
 
 
 
SECTION F   TRADITIONAL MEDICATION 
 
39. Since you started hypertension treatment, have you consulted the traditional healer? 
 Yes   No 
 
40. If yes, why? No improvement  Not satisfied with health worker/facility  
  To speed up healing  others (specify)................................. 
 
41. What advice did the traditional healer give you about hypertension and its treatment? 
 Stop modern medicine   Adding traditional medicine helps in treatment 
 refer back to health facility  others (specify)................................ 
 
42. Are you taking any traditional treatment at the moment with the hypertension treatment?
 Yes   No 
 
 
 
SECTION G    OTHER CO-MORBIDITIES 
 
43. Do you have any other chronic illness like Diabetes mellitus, HIV, Epilepsy, arthritis/ joint pains, 
asthma?     Yes  No  Others (Specify)……………………………… 
 
44. Have you ever been diagnosed of depression or low mood? Yes  No 
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45. Are you on any other drug for chronic illness or medical conditions mentioned above? 
 Yes  No 
 
46. Do you smoke? Yes   No 
 
47. Do you think that your smoking affects your hypertension treatment?   
 Yes   No 
 
48. If yes, how?         No effect on blood pressure  Increases blood pressure 
 Reduces blood pressure   others (specify)............................. 
 
 
49. Do you drink alcohol/beverage/spirit/chibuku?  Yes  No 
 
 
50. Do you think that your alcohol/chibuku consumption affect your hypertension treatment?
 Yes  No 
 
51. If yes, how? If yes, how?         No effect on blood pressure  Increases blood 
pressure  Reduces blood pressure  others (specify)............................. 
THANK YOU 
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